Androcur serious cases of tumor development observed during pregnancy well after stopping treatment - LCI

LCI Androcur

Androcur serious cases of tumor development observed during pregnancy well after stopping treatment - LCI

HEALTH - This medication, produced by the Bayer laboratory and used to relieve certain forms of endometriosis increases the risk of tumor in the brain when taken for a long time and in high doses.

A new study reveals that four new cases have been discovered. These are serious cases of development of intracranial tumors occurring during pregnancy several years after the end of Androcur. This drug from the Bayer laboratory and its generics can multiply up to 20 (after 5 years of treatment) and even more, the probability of tumors (meningiomas) in women treated for a long time and in high doses, had shown a study of health insurance made public in August 2018.

" The occurrence and severity of these cases (during pregnancy, editor's note) raises the question of driving in women considering pregnancy following treatment with Androcur or one of its generics ," notes the ANSM. " Progesterone produced massively during pregnancy increases the size of meningioma already present even if the Androcur is arrested ," said Dr Isabelle Yoldjian.

Find the other Amavea articles here